ABC Report Examines Ivermectin Use for Cancer After Celebrity Podcast
Embed this grade
Why this grade: B+: Core claims on prescription surge and lack of clinical evidence are well-supported by JAMA study and medical consensus; minor overstatement on 'tripled' prescriptions and limited context on ongoing early trials
Why this lean: Emphasizes risks, mainstream medical caution, and political associations with right-leaning figures while highlighting unproven alternatives over any potential signals from preclinical or real-world data
Disagree with this grade or political lean?
Tell us why. Your note is reprocessed through the same grading logic; if the output is still off the report is removed, and if it holds up it stays.
Topics in this report
Summary
ABC News segment profiles former NHL player Ron Duguay using high-dose ivermectin alongside chemotherapy for stage 4 colon cancer, attributing his tumor reduction partly to the drug after a Joe Rogan podcast. It reports a JAMA Network Open study showing ivermectin-benzimidazole prescriptions roughly doubled overall and more than doubled among cancer patients following the January 2025 Mel Gibson appearance. Doctors warn of risks including seizures or death at high doses and potential delay of proven treatments. Poison control calls rose sharply. The piece also notes Scott Adams tried ivermectin for prostate cancer without success before his death.
Editorial Assessment
The report accurately captures the post-podcast prescribing spike documented in peer-reviewed data and correctly states that rigorous human trials confirming efficacy are absent. It underplays the distinction between in-vitro/mouse data and one ongoing phase 1/2 trial with preliminary mixed results. Framing highlights celebrity influence and political context while omitting counter-claims from small observational cohorts reporting self-reported benefit. Viewers may miss that individual anecdotes like Duguay's involve concurrent standard care and that poison-center data cited aligns with prior COVID-era patterns rather than solely recent cancer use.
Key Moments
JAMA study links Joe Rogan/Mel Gibson podcast to sharp rise in ivermectin prescriptions for cancer
UCLA-led cohort study in JAMA Network Open (May 2026) found prescriptions more than doubled among cancer patients after January 2025 episode
No firm proof ivermectin beats cancer; only test-tube and mouse studies
Confirmed by ASCO, American Cancer Society, and NCI statements; only preclinical data and one early-phase trial with pending results
Ron Duguay credits ivermectin for rapid tumor reduction in stage 4 colon cancer
Duguay uses it alongside chemotherapy; he paused during a separate clinical trial
Scott Adams tried ivermectin for prostate cancer; it did not work and he died six months later
Adams publicly stated ivermectin and fenbendazole failed; he died in early 2026 after May 2025 diagnosis
Notable Concerns
- Slight exaggeration of prescription increase ('tripled' vs study ~2.5-fold for cancer patients)
- Limited discussion of early-phase trials or real-world observational data
Sources Consulted
- Ivermectin-Benzimidazole Prescribing Following Celebrity Endorsement
- Ivermectin prescriptions more than doubled after a celebrity endorsed it as a cancer treatment
- Some cancer patients turn to ivermectin despite lack of evidence it works
- What to Know About Ivermectin
- Recommending Against Ivermectin and Fenbendazole for Cancer Treatment
- Scott Adams, 'Dilbert' creator, shares prostate cancer diagnosis